Máj- és epeúti rák: vizsgálatok itt: Kína
621 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaOncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 74
- Run by
- Fudan University
See details and how to joinNCT06919848 - 2/3. fázisTaking peopleA Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
- Where
- Lishui, Nanjing
- Életkor
- 18 év and over
- People
- 300
- Run by
- Zhejiang Raygene Pharmaceuticals Co., Ltd
See details and how to joinNCT06844357 - 2. fázisTaking peopleCryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 92
- Run by
- Fudan University
See details and how to joinNCT06860477 - No phaseTaking peopleTACE Combined Surgery for the Resectable Huge HCC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 326
- Run by
- Sun Yat-sen University
See details and how to joinNCT06898398 - 2. fázisTaking peopleA Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 49
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06620848 - 2. fázisTaking peopleEfficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC
- Where
- Jinan
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Lei ZHAO
See details and how to joinNCT06904014 - 2. fázisCsak meghívásosCamrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06901622 - 2. fázisNot yet taking people in KínaIcariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 25
- Run by
- Hua Li
See details and how to joinNCT06900478 - No phaseTaking peopleBiomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
- Where
- Shanghai
- People
- 240
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06382103 - No phaseTaking peopleHAIC Compared With TACE in Huge Hepatocellular Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 664
- Run by
- Sun Yat-sen University
See details and how to joinNCT06641713 - 1/2. fázisNot yet taking people in KínaIcaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Zhiyong Huang
See details and how to joinNCT06896396 - No phaseTaking peopleCombined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
- Where
- Quanzhou, Wuhan
- Életkor
- 18 év and over
- People
- 300
- Run by
- Ze-yang Ding, MD
See details and how to joinNCT05713994 - No phaseTaking peopleThe Overall Survival of Patients With Unresectable HCC in Real-life
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- Humanity & Health Medical Group Limited
See details and how to joinNCT03612726 - 1. fázisTaking peoplePhase I Study of OriC902 in Treatment of Advanced HCC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 44
- Run by
- Peking University
See details and how to joinNCT06891742 - No phaseTaking peopleA Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Ruijin Hospital
See details and how to joinNCT06567353 - No phaseBefejeződöttRegional Lymph Node Metastasis and Survival Outcomes in Advanced HCC
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 300
- Run by
- Zhongda Hospital
See details and how to joinNCT06876753 - 3. fázisTaking peopleA Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 570
- Run by
- Akeso
See details and how to joinNCT05489289 - 3. fázisTaking peopleA Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
- Where
- Changsha, Hangzhou, Nanjing, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 469
- Run by
- Akeso
See details and how to joinNCT06371157 - No phaseTaking peoplePlasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 260
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06864221 - 2. fázisTaking peopleEfficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06870942 - 2. fázisTaking peopleA Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy
- Where
- Hunan
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06742892 - No phaseNot yet taking people in KínaLiver Cancer Prognosis Investigation Study
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 5000
- Run by
- Sun Yat-sen University
See details and how to joinNCT06623734 - 2. fázisTaking peopleA Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
- Where
- Harbin, Shanghai
- Életkor
- 18 év to 75 év
- People
- 54
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06778031 - No phaseTaking peopleExploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 38
- Run by
- Zhujiang Hospital
See details and how to joinNCT06861114 - 2. fázisTaking peopleNeoadjuvant Therapy of HAIC(GEMOX) Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
- Where
- Chengdu, Nanjing, Ningbo
- Életkor
- 18 év to 75 év
- People
- 33
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06208462